Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Filing tables
Filing exhibits
ADAP similar filings
Filing view
External links
Exhibit 15.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Adaptimmune Therapeutics plc:
We consent to the incorporation by reference in the registration statement (No. 333-203929) on Form S-8 of Adaptimmune Therapeutics plc of our report dated October 12, 2015 with respect to the consolidated balance sheets of Adaptimmune Therapeutics plc as of June 30, 2015 and 2014, and the related consolidated statements of income, comprehensive loss, changes in equity and cash flows for each of the years in the three-year period ended June 30, 2015 which report appears in the June 30, 2015 annual report on Form 20-F of Adaptimmune Therapeutics plc.
/s/ KPMG LLP
Reading, United Kingdom
12 October 2015